Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Invested Capital (2022 - 2025)

Historic Invested Capital for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to -$7.7 million.

  • Envoy Medical's Invested Capital rose 5868.52% to -$7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.7 million, marking a year-over-year increase of 5868.52%. This contributed to the annual value of -$18.8 million for FY2024, which is 118614.33% down from last year.
  • According to the latest figures from Q3 2025, Envoy Medical's Invested Capital is -$7.7 million, which was up 5868.52% from -$29.9 million recorded in Q2 2025.
  • Envoy Medical's 5-year Invested Capital high stood at $5.0 million for Q3 2023, and its period low was -$47.5 million during Q1 2023.
  • Over the past 4 years, Envoy Medical's median Invested Capital value was -$18.8 million (recorded in 2024), while the average stood at -$20.5 million.
  • Its Invested Capital has fluctuated over the past 5 years, first surged by 12889.71% in 2023, then crashed by 118614.33% in 2024.
  • Quarter analysis of 4 years shows Envoy Medical's Invested Capital stood at -$35.9 million in 2022, then skyrocketed by 95.91% to -$1.5 million in 2023, then tumbled by 1186.14% to -$18.8 million in 2024, then surged by 59.34% to -$7.7 million in 2025.
  • Its Invested Capital stands at -$7.7 million for Q3 2025, versus -$29.9 million for Q2 2025 and -$24.2 million for Q1 2025.